Why the study?
Data are limited regarding the prognostic value of lymphocyte-to-monocyte ratio in patients with STEMI after hospital discharge.
Does decreased admission lymphocyte-to-monocyte ratio predict long-term MACE and all-cause mortality in hospital survivors of STEMI?
Population
1369 STEMI patients
Comparison
LMR tertiles: T1 (≥2.84) vs T2 (1.85-2.83) vs T3 (<1.85)
Design
Retrospective observational cohort study
Follow-up
Median 556 days
Authors
Loading...
LMR may refine post-discharge risk stratification in STEMI survivors; leaves open incremental value over standard models.
Does decreased admission lymphocyte-to-monocyte ratio predict long-term MACE and all-cause mortality in hospital survivors of STEMI?
A lower admission lymphocyte-to-monocyte ratio serves as an independent prognostic marker for increased long-term MACE and all-cause mortality in STEMI patients after hospital discharge.
Cai et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: